Chargement en cours...
Single or combined immune checkpoint inhibitors compared to first‐line chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary To determine the efficacy and safety of first‐line immune checkpoint inhibitors, or immuno‐oncology therapy (IO), as monotherapy or in combination for patients with advanced non‐small cell lung cancer (NS...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6364791/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013257 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|